Currently the most popular drug in the family of Invokana and Farxiga, Jardiance stimulates the kidneys to expel glucose from the bloodstream into the urine. As a result patients with type 2 diabetes benefit by losing weight and improving their blood pressure. A relatively large study suggests Jardiance might also slightly reduce the risk of all cause mortality and decrease the likelihood of death from cardiovascular disease. Although these results appear statistically significant, the absolute improvement remains small at less than 3%. No reduction occurs in the incidence of heart attacks or stroke. Blood glucose and hemoglobin A1c fall only modestly.

свернуть